chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Side effects from the second dose were LESS severe than expected (no fever); The pain more or less subsided within 36 hours; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (Side effects from the second dose were LESS severe than expected (no fever)) and PAIN (The pain more or less subsided within 36 hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects from the second dose were LESS severe than expected (no fever)) and PAIN (The pain more or less subsided within 36 hours). At the time of the report, VACCINATION COMPLICATION (Side effects from the second dose were LESS severe than expected (no fever)) outcome was unknown and PAIN (The pain more or less subsided within 36 hours) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported. It was reported that the pain was more or less subsided within 36 hours.   Reporter did not allow further contact
Half dose still PFS,unsure howmuch administered; Half dose still PFS,unsure howmuch administered; This case was reported by a nurse via call center representative and described the occurrence of underdose in a 5-year-old male patient who received DTPa-IPV (Kinrix) (batch number H9FM5, expiry date 7th May 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 17th August 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 17th August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced underdose and incomplete dose administered. On an unknown date, the outcome of the underdose and incomplete dose administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 17-AUG-2022 Reporter's Comments: Nurse reported that she was administered a dose of Kinrix to patient, and the patient pulled away during administration.  The nurse stated that she was unsure how much of the dose the patient received, half of the dose was still left in the PFS, and she believed most of the part that was injected did not go into the patient.  At the time of reporting, the dose had not been repeated.  The reporter consented to follow up.  The Vaccine Administration Facility was the same as Primary Reporter. Additional supportive information: The half of the dose was still left in the PFS and how much of the dose the patient received was unsure which led to Under dose and incomplete dose administered.
Vaccines-seasonal flu and PNEUMOVAX -16OCT09, per VA records. Diagnosed with Guillain Barre Syndrome 12/29/09 at hospital.
4/15/05 mother brought child in clinic with edematous, red, warm right arm at injection site. Mother applied ice and gave child Benadryl PO. Denies any pain at site. 4/18/05 phone call to follow up on child. Mother stated arm much better only small amt erythema present.
Redness and pinchy feeling in her face.  Given allegra and watched for 30 minutes post injection.
Pt developed a headache then felt lightheaded, then collapsed and had a brief clonic episode of his upper arms.  This happened later that night around 10 pm.  With that episode he also developed a headache but denies lightheadedness prior to experiencing a loss of consciousness and brief clonic movements again. with vomiting after.
This spontaneous report was received from a pharmacist referring to a 75 year old patient. The patient's concurrent conditions, medical history and concomitant medications were not provided. On an unspecified date in February 2018, the patient was vaccinated with the first dose of PNEUMOVAX 23 (strength, dose, route, frequency, lot # and expiration date were not provided) for prophylaxis. On an unspecified date in August 2018, the patient inadvertently received a second dose of PNEUMOVAX 23 (strength, dose, route, frequency, lot # and expiration date were not provided). No adverse effects reported.
Legs been hurting and achy; Muscles felt much weaker in the legs and was getting worse; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Legs been hurting and achy) and MUSCULAR WEAKNESS (Muscles felt much weaker in the legs and was getting worse) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 007M20A) for COVID-19 vaccination.     Concomitant products included LOSARTAN, FLUOXETINE, GABAPENTIN and METOPROLOL for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Legs been hurting and achy) and MUSCULAR WEAKNESS (Muscles felt much weaker in the legs and was getting worse). At the time of the report, PAIN IN EXTREMITY (Legs been hurting and achy) and MUSCULAR WEAKNESS (Muscles felt much weaker in the legs and was getting worse) outcome was unknown. Unknown          No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-207654 (Patient Link).
17 year old patient received the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient received the vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008b21-2a) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient received the vaccine). On 22-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient received the vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported. No concomitant medications were reported.
Arm of injection along with trapezius and ipsilateral violent muscle contracture woke me out of sound sleep, pulling neck and head sideways to the left and was unable to straighten left arm without increasing the constant and severe contracture of neck feeling tearing in the left shoulder and left posterolateral neck; took Benedryl Allergy and cyclobenziprine as well as morning dose of Clonazapam resulting in less severe contracture; took ibuprophen for pain lessening severity; utilized a sling for Left shoulder, Sought aid of Chiropractors; Physiatrist(scheduled for 10./05/2021) also recommended by Neurosurgeon; PMD/Nurse Notified of adverse reaction; Neurosurgeon assessed all/ordered testing and contacted Physiatrist to expedite visit stating Botox may be indicated to block ongoing contractures.
shingles; zoster-related conditions; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 31-MAY-2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose # and route not specified) for the long-term prevention of shingles and zoster-related conditions (prophylaxis). At the time of the patient's vaccination, the patient relied on the warning label affixed to vaccine live (ZOSTAVAX), and the information relayed through patient's healthcare providers that vaccine live (ZOSTAVAX) was an effective in preventing shingles on a permanent basis and did not carry any significant risk of adverse effect, which induced the patient to be vaccinated. On the same date, the patient's healthcare provider relied in the warning label affixed to the vaccine live (ZOSTAVAX) vaccine, believed that it was effective in preventing shingles on a long-term or permanent basis, and believed that it did not carry any significant risk of adverse effects. Subsequent to the patient's vaccine live (ZOSTAVAX) vaccination, the patient was treated for shingles and other-related conditions by various healthcare provides. As a direct and proximate result of the patient's use of the vaccine live (ZOSTAVAX) vaccine, the patient had and will continue ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs included care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other loses and damages, and will continue to suffer such losses, and damages in the future. The outcome of the events was unknown.
I had difficulty moving the next day and I started having a strange pain going down the right side. Starting with my upper arm and down my side. It started spreading around my back where my bra is and then went around my body and my breasts were sore. I have not been able to wear a bra since this started, it really hurts. Just a pain - no rash. At one point,  I was leaning over in pain and if I were to sneeze I would have fallen over. Basically catching my breath was difficult. It is hard to tell how long it lasted, I was traveling for 12 days., I started doing better on the last three days and three days after I got home, I was bitten by a tick and have Lyme Disease. I am not sure what pain is from what thing. There were 4-5 days in there where I was feeling okay. I did see a doctor for the Lyme Disease but not for the reaction from the vaccine. I was given medication for Lyme disease. I am currently feeling better about 14 days after the vaccine.
When vaccine was injected into the Left deltoid, the majority of the vaccine trickled down her arm - discovered the hub to the needle was loose.
pt recvd vax 17NOV88 & was dx w/Hep B & lab eval in DEC92 revealed liver enzymes remained elevated; No further details were provided;
Left arm swelling and redness extending 6-8 inches beyond injection site. Pt self treated with TYLENOL. Advised ice and BENADRYL prn.
Initial report received from healthcare professional on 16 Feb 2010: This patient with unknown medical history was vaccinated with S-OIV FLUVIRIN (batch no. 102046P1), 0.5ml, IM, on 18 Nov 2009. The patient experienced low grade fever (99 F) on 19 Nov 2009. Outcome of event was reported ongoing.
Patient experienced a hive/rash like reaction all over the body around 4 days after the vaccine that progressively worsened. Patient went to to see a doctor on 2/17 and the doctor prescribed hydroxyzine and a cream to help with the hives, which helped lessen the symptoms but was unable to rule out that the reaction was caused by the vaccine. The doctor recommended that the patient still receives the 2nd dose of the vaccine.
Post vaccine in waiting lot - Numbness, paresthesia to right arm/side. Negative for facial drooping, SOB, tachycardia, chest pain. A/O x3. Medical Hx of hypercholesterolemia, no other issues.
Egan as itchiness, still extreme itchiness with welts and rash over entire body
Received flu shot at 1:15 in work office. 1:17 felt really hot and told my co-worker something was wrong. She explained that my face was extremely red and compared it to the color of the coke can and that my eyes looked like they were going to bleed because they were so bloodshot. She walked me to the nurses station and I felt like my head was getting bigger and bigger and I was going to pass out. The nurse took my blood pressure and it was 179/90 and my heart rate was 118. Two hours later my blood pressure was 142/83. I just didn't feel good for the rest of the day/evening.
On 01-13-2021 I developed pain at the bottom of my left lung. I was painful to breathe. I saw my PCP on 01-19-2021. I also went to the hospital where they performed chest x-ray, blood work, urine test and an ultrasound of the chest. I did not stay any days at the hospital. My exams were negative.
Mother noticed swelling and redness childn's left arm day after immunization in the evening.  Redness and swelling went from left elbow to neck.  Arm was hot-mother took child to ER at midnight.  Child given epineprine and prescription for Benadryl, Zantac and pediaprid.
Headache; Chills; not feeling well; tingling all over her arms, face and legs; severe fast heartbeat; Dizziness; difficulty breathing; This is a spontaneous report from a contactable consumer. A 58-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL0142, expiry: Mar2021), via an unspecified route of administration on 03Jan2021 at a single dose for covid-19 immunization. The patient has no medical history and no concomitant medications as the patient reported she was healthy. The patient experienced severe reactions, she was in the hospital  twice. On 10Jan2021, the patient experienced difficulty breathing, severe fast heartbeat and dizziness. On 13Jan2021, patient had headache, chills, not feeling well, and tingling all over her arms, face and legs. The patient further stated that a week after getting the vaccine, last Sunday, she had a severe reaction and was hospitalized twice due to the events. Exactly one week after receiving the vaccine, on Sunday 10Jan2021, patient ended up in an ambulance due to dizziness, fast heart rate, and difficulty breathing which all started on 10Jan2021. She confirms that she was admitted to the hospital that day, and she was discharged the next day, on 11Jan2021 in the afternoon. On 13Jan2021, in the afternoon, the other symptoms of headache, chills, not feeling well, and tingling all over her arms, face and legs, started. Patient went back to a different hospital, to the emergency room, on Wednesday 13Jan2021, but was not admitted at that time. Patient mentioned the difficulty breathing was okay, but she does not want to say it was 100% better because she was still having a little bit of difficulty. Caller states that the dizziness and fast heart rate are still pretty serious. It was reported that the patient was hospitalized for the event fast heart rate from 10Jan2021 to 15Jan2021, and chills, not feeling well, and tingling all over her arms, face and legs on unspecified date. Patient was due to get the second dose on 24Jan2021, and she does not know if she should because she had side effects to the first dose. Patient seen several doctors and she had a cardiologist that was monitoring her, and she has had a stress test and labs and those are all normal. patient confirms that the product was no specifically prescribed to her, but it was given via workplace policy as she works for a hospital. The outcome of the events difficulty breathing was recovering and not recovered for all the other events.  No follow-up attempts are possible; information about batch number has been obtained.
10 days p/vax low grade fever x 2 days, macular papular rash on face, generalized knee pain & swelling x 2 days. Severe pain & swelling from elbow to hands x 5 days; 2.5 wk later paresthesia of finger present; non immune to Rubella prior.
At 3:50 PM, Mother returned to health department (approx. 30 minutes after vaccines were administered.) Child demonstrated facial swelling, watery eyes, occasional wheezing, and hives.  Child pulled at his tongue at times, no swelling of the tongue was noted. EMS activated and child transferred to ETC at 3:55 PM.
patient received an expired VAQTA; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.     On 19-JUL-2021, the patient was vaccinated with expired dose of hepatitis a vaccine, inactivated (VAQTA) lot # T014836, expiration date 17-JUL-2021, 0.5 milliliter, once for prophylaxis (anatomical location and route of administration were not reported). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T014836; expirationdate: 17-JUL-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Immediate mid section itching and hives; Immediate mid section itching and hives; Extremely swollen left arm and hand within two days; Hives turned to water blisters; This is a spontaneous report from a contactable consumer. A 91-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for COVID-19 immunization. The patient had no medical history and no known allergies. The patient had no prior COVID vaccination, no COVID test post vaccination and no other vaccine in the last four weeks. The patient had unspecified concomitant medications for the last two weeks. The patient experienced immediate mid-section itching and hives. Extremely swollen left arm and hand within two days. Hives turned to water blisters, unaffected by prednisone. Blisters first appeared on arms, back and stomach and advanced to underarms and groin area. Hospitalization for five days was necessary. The events started on 09Feb2021. Intravenous steroids and antibiotics were given as treatment. The second dose of BNT162B2 was given on 18Feb2021 11:00 on the left arm. The outcome of the events was recovered.  Information on the lot/batch number has been requested.
Information has been received from a health professional through a Merck pregnancy registry concerning a 21 year old pregnant female, with a history of 2 full-term births, who on 7/13/04 was vaccinated with a dose of VARIVAX. Secondary concomitant therapies included a 0.5 ml dose of MMR II and a dose of RECOMBIVAX HB, also given on 7/31/04. An additional dose of RECOMBIVAX HB (manufacturer unknown) was given on 10-AUG-2004 and an additional dose of VARIVAX was given on 31-Aug-2004. Concomitant medications included prenatal vitamins from September 2004, 1 1000mg dose of Zithromax on 9/22/04 for the chlamydia infection and 1 125mg, IM, dose of Rocephin, 250 mg, on 9/22/04 for the chlamydia infection. Her LMP was 3/15/04 and her EDD was 12/20/04. The health professional reported that the "patient knew she was pregnant when vaccinated". The patient had ultrasounds on 10/1/04 and 12/1/04, to determine size and date and were both normal. Follow-up info from a health professional indicated that the patient had a healthy baby boy that was "4 months ago", on approximately 1/05. It was noted that the patient had an appointment schedules for this afternoon. Follow-up info from a physician indicated that the patient experienced a chlamydia infection during pregnancy which was diagnosed at the initial obstetrician visit. There was no complication during pregnancy, no complication during labor/delivery, and no diagnostic test during pregnancy on 12/28/04. 40 weeks and 5 days from her LMP, the patient gave birth to a normal, 3 lb 10 oz male, with no complication or abnormalities, and no feature of congenital varicella zoster syndrome. There was no product quality complaint involved. Additional info has been requested.
Information has been received from pharmacist concerning a pt who was vaccinated with a dose of varicella virus vaccine live. The pharmacist reported that a titer was drawn, which was low, indicating that the pt failed to seroconvert. Unspecified medical attention was sought. Additional information has been requested.
Influenza vaccine given SC, not IM.  Member experienced erythema, swelling, heat 2.5" x 1". Member reported pain and itching at injection site.  Duration of symptoms- 72hrs.
48 hours post immunizations. Mild URI symptoms rhinorrhea and Fever with tmax 103.5 degrees lasting x 3 days then fever broke and had morbilliform rash starting on neck, spreading to torso, face and extremities.  Symptoms follow roseola infantum very well.   Pediarix, HIB, Pneumococcal vaccines given 3/24/14.
I got up the morning after my injection when I went in the bathroom, I noticed in the mirror that I had a blister where the tape was on my arm and it had pulled out a little. I had 2 pieces of tape in that area. Then I noticed another blister that was closer to the injection site that was bigger. I had a 4 o'clock dental appointment that following day I asked them to take a look. They advised me to go to my internist. I instead went to the vaccine site and they stated it looked like I had a reaction to the tape and provided me a sample of the tape. They recommended I go to my internist. When I tried to go to my internist, she was closed. I went to the Urgent Care instead, I provided them with a sample of the tape and they stated it looked like I was having a reaction to the tape. By the time I had gotten to the urgent care location the blister that had burst was now raised again . On the 2nd of April I was able to see my internist and by that time the blister had gotten bigger. My internist's assistant burst the blister with no further action.
Within 2 days of first injection my dad could not hold his head up off of his chest, had muscle weakness and trouble walking.  he had difficulty breathing.  He was hospitalized by day 4 and progressively got worse.  He was kept on a bi-pap within a week and also put on a feeding tube through the nose.  He was in the hospital 25 days.  After about 2 weeks in he was diagnosed with Myesthenia Gravis and treated with infusions.  He died in the hospital.
Two days after receiving the first shot of the Moderna Covid-19 vaccine, I experienced pain at injection site, chills, joint pain  and pain in my wrist. After the second shot, which I received,  I developed pain in my other hand and fingers. Now I have pain in both my hands, all my fingers and wrists. I also still experience bouts of chills and sometime I still have days when I have pain at the injection site. The pain is so severe in my hands and fingers that I can't close my hands.
Low grade fever, muscle aches, feeling foggy, feeling tiered, moderate pain at injection site. Treated with Ibuprofen, bed rest. Felt better after three days.
5-10 minutes after injection Numbness in middle of tongue for 10 minutes (3/10 discomfort) Bottom Jaw stiffness and soreness with heavy sensation for 10 minutes following end of tongue numbness (4/10 discomfort)  12 hours later:  Sun burn feeling in middle of chest for 10 minutes (4/10 discomfort)